Clinical Trials Browser

Observational × Lenalidomide × Lymphoid × Clear all

NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Head & NeckLymphoidOther hematologic neoplasm

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

NCT04036448 2025-03-11

RevlimidPMS

LymphoidMyeloid

Lymphoma, Follicular, Myelodysplastic Syndromes, Recurrence, Lymphoma, Mantle-Cell

NCT03647124 2025-03-04

A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma

Recurrence, Lymphoma, Mantle-Cell

NCT05923879 2023-06-28

Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma

Lymphoma, Large B-Cell, Diffuse

NCT05899621 2023-06-12

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Lymphoma, Lymphoma, Follicular

NCT05883709 2023-06-01

A Real-world Study of Tafasitamab in Combination With Lenalidomide in Patients withR/R DLBCL

Lymphoma, Large B-Cell, Diffuse

NCT05690191 2023-01-19

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

Enrolling by invitation

Lymphoma, Large B-Cell, Diffuse

NCT04109872 2020-02-05

Lenalidomide Observational Study in Patients With Mantle Lymphoma in Relapse/Refraction. Spanish Programme RRMCL Results.

Recurrence, Lymphoma, Mantle-Cell

NCT03715296 2019-07-08

Lenalidomide Based Immunotherapy in the Treatment of DLBCL

Lymphoma, Large B-Cell, Diffuse